When the US Food and Drug Administration introduced its Digital Health Software Precertification (Pre-Cert) in 2017, the idea was to create a streamlined process for more efficient regulatory oversight of software-based medical devices.
To achieve this, the FDA would allow manufacturers of these devices to update the software without having to submit the required premarket 510(k) submissions if certain conditions are met